We work closely with a broad range of partners, including industry, government and charitable organisations, to deliver scientific breakthroughs and impact.
Industrial partners come from a variety of sectors and range from small manufacturing enterprises through to large corporations at local to international level. We are dedicated to developing innovative biological processes for the agricultural, energy, food, chemical, pharmaceutical and related industries, ensuring that our science has a commercial impact.
Waste from sugarcane
This multi-partner project investigates the potential to use waste from sugarcane processing to produce bio-based citric acid, which has a growing market in the food, beverage and cleaning sectors.
Scaling-up biobased products
In partnership with GCCE we launched BDC, an open-access R&D centre working at the interface between academia and industry to develop, scale-up and help commercialise biobased products and processes.
Researchers at CNAP and GlaxoSmithKline Australia (now Sun Pharmaceutical Industries Ltd) made a key genetic discovery in the opium poppy for the biosynthesis of a major pharmaceutical. Sun Pharma have used this discovery to develop bespoke commercial poppy varieties.